ANTIVIRAL THERAPY, cilt.18, sa.4, ss.561-566, 2013 (SCI-Expanded)
Background: To determine the efficacy of pegylated interferon-alpha (PEG-IFN-alpha) therapy for 24 months in chronic delta hepatitis (CDH).